| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8822674 | European Journal of Radiology | 2018 | 7 Pages |
Abstract
As compared to RECIST 1.1, PERSIST 1.0 may be more suitable for evaluation of neoadjuvant therapeutic response to esophageal cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Soichi Odawara, Kazuhiro Kitajima, Takayuki Katsuura, Yasunori Kurahashi, Hisashi Shinohara, Koichiro Yamakado,